Search Results

Filter
  • 1-10 of  3,451 results for ""Orphan Drug Production""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

The Orphan Drug Act at 40: Legislative Triumph and the Challenges of Success.

Subjects: Orphan Drug Production* ; Drug Approval*; United States

  • Source: The Milbank quarterly [Milbank Q] 2024 Mar; Vol. 102 (1), pp. 83-96. Date of Electronic Publication: 2023 Dec 12.Publisher: Blackwell Publishers Country of Publication: United States NLM ID: 8607003 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
Academic Journal

Trends in orphan medicinal products approvals in the European Union between 2010-2022.

  • Authors : Bouwman L; Faculdade de Farmácia, Universidade de Lisboa, Lisbon, Portugal. .; Laboratory of Systems Integration Pharmacology, Clinical and Regulatory Science, Research Institute for Medicines of the University of Lisbon (iMED.ULisboa), Lisbon, Portugal. .

Subjects: Orphan Drug Production* ; Rare Diseases*/Rare Diseases*/Rare Diseases*/drug therapy; Humans

  • Source: Orphanet journal of rare diseases [Orphanet J Rare Dis] 2024 Feb 27; Vol. 19 (1), pp. 91. Date of Electronic Publication: 2024 Feb 27.Publisher: BioMed Central Country of Publication: England NLM ID: 101266602 Publication Model: Electronic Cited Medium: Internet ISSN: 1750-1172

Record details

×
Academic Journal

A new drug for rare diseases: pozelimab for CHAPLE disease.

  • Authors : Belot A; Centre International de Recherche en Infectiologie, Inserm U1111, Université Claude Bernard Lyon 1, CNRS UMR5308, ENS de Lyon, Lyon, France; Pediatric Nephrology, Rheumatology, Dermatology, Hôpital Femme Mère Enfant, Hospices Civils de Lyon, Bron 69677, France. Electronic address: .

Subjects: Rare Diseases*/Rare Diseases*/Rare Diseases*/drug therapy ; Orphan Drug Production*; Humans

  • Source: Lancet (London, England) [Lancet] 2024 Feb 17; Vol. 403 (10427), pp. 592-593. Date of Electronic Publication: 2024 Jan 23.Publisher: Elsevier Country of Publication: England NLM ID: 2985213R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-547X

Record details

×
Academic Journal

Analysis of US Food and Drug Administration new drug and biologic approvals, regulatory pathways, and review times, 1980-2022.

  • Authors : Seoane-Vazquez E; Department of Pharmaceutical Economic and Policy, Chapman University School of Pharmacy, Irvine, CA, USA. .; Economic Science Institute, Argyros School of Business and Economics, Chapman University, Orange, CA, USA. .

Subjects: Orphan Drug Production* ; Biological Products*/Biological Products*/Biological Products*/therapeutic use; United States

  • Source: Scientific reports [Sci Rep] 2024 Feb 09; Vol. 14 (1), pp. 3325. Date of Electronic Publication: 2024 Feb 09.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Orphan drug development: Challenges, regulation, and success stories.

Subjects: Orphan Drug Production*; Humans ; India

  • Source: Journal of biosciences [J Biosci] 2024; Vol. 49.Publisher: Springer India, in co-publication with Indian Academy of Sciences Country of Publication: India NLM ID: 8100809 Publication Model: Print Cited

Record details

×
Academic Journal

Orphan Drug Label Expansions: Analysis Of Subsequent Rare And Common Indication Approvals.

  • Authors : Miller KL; Kathleen L. Miller (), Department of Health and Human Services, Washington, D.C.; Lanthier M

Subjects: Orphan Drug Production* ; Rare Diseases*/Rare Diseases*/Rare Diseases*/drug therapy; Child

  • Source: Health affairs (Project Hope) [Health Aff (Millwood)] 2024 Jan; Vol. 43 (1), pp. 18-26.Publisher: Project Hope Country of Publication: United States NLM ID: 8303128 Publication Model: Print Cited Medium: Internet ISSN: 1544-5208

Record details

×
Academic Journal

Cost of Exempting Sole Orphan Drugs From Medicare Negotiation.

  • Authors : Vogel M; John F. Kennedy School of Government, Harvard University, Cambridge, Massachusetts.; Zhao O

Subjects: Medicare* ; Orphan Drug Production*; Humans

  • Source: JAMA internal medicine [JAMA Intern Med] 2024 Jan 01; Vol. 184 (1), pp. 63-69.Publisher: American Medical Association Country of Publication: United States NLM ID: 101589534 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Uptake of orphan drugs in the WHO essential medicines lists.

  • Authors : Costa E; WHO Collaborating Centre for Pharmaceutical Policy and Regulation, Department of Pharmacoepidemiology, Utrecht University, Utrecht, Kingdom of the Netherlands.; Moja L

Subjects: Orphan Drug Production* ; Drugs, Essential*; Child

  • Source: Bulletin of the World Health Organization [Bull World Health Organ] 2024 Jan 01; Vol. 102 (1), pp. 22-31. Date of Electronic Publication: 2023 Oct 31.Publisher: World Health Organization Country of Publication: Switzerland NLM ID: 7507052 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
Academic Journal

The European landscape for gene therapies in orphan diseases: 6-year experience with the EMA Committee for Orphan Medicinal Products.

  • Authors : Palomo GM; Agencia Española de Medicamentos y Productos Sanitarios, Calle Campezo 1 Edificio 8, 28022 Madrid, Spain; Committee for Orphan Medicinal Products, European Medicines Agency, Domenico Scarlattilaan 6, 1083 HS Amsterdam, the Netherlands. Electronic address: .

Subjects: Rare Diseases*/Rare Diseases*/Rare Diseases*/genetics ; Rare Diseases*/Rare Diseases*/Rare Diseases*/therapy ; Orphan Drug Production*

  • Source: Molecular therapy : the journal of the American Society of Gene Therapy [Mol Ther] 2023 Dec 06; Vol. 31 (12), pp. 3414-3423. Date of Electronic Publication: 2023 Oct 04.Publisher: Cell Press Country of Publication: United States NLM ID: 100890581 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Evaluating the impact of the FDA's orphan drug designation on share prices of biotechnology companies.

  • Authors : Williamson J; Faron Pharmaceuticals, Joukahaisenkatu 6, 20520 Turku, Finland. Electronic address: .; Spicer AJ

Subjects: Orphan Drug Production* ; Drug Approval*; United States

  • Source: Drug discovery today [Drug Discov Today] 2023 Dec; Vol. 28 (12), pp. 103807. Date of Electronic Publication: 2023 Oct Publisher: Elsevier Science Ltd. Country of Publication: England NLM ID: 9604391 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
  • 1-10 of  3,451 results for ""Orphan Drug Production""